IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Sheinelle Jones speaks to an expert about the benefits of nature prescriptions | Wellness TODAY

    06:52
  • Sheinelle Jones learns about three organizations making the outdoors more inclusive | Wellness TODAY

    04:46
  • Sheinelle Jones learns tips to stay safe in nature | Wellness TODAY

    04:11
  • Sheinelle Jones learns about a nonprofit making scuba diving more accessible | Wellness TODAY

    03:36
  • Stroke survivor, 28, shares symptoms and warning signs

    04:45
  • NYC's last public pay phones removed from Times Square

    00:31
  • Second military plane carrying baby formula set to arrive in US

    00:18
  • How to identify a monkeypox rash: Symptoms to look out for

    02:18
  • CDC warns LGBTQ community at higher risk to get monkeypox

    01:56
  • Sheinelle Jones learns about the benefits of spending time outdoors | Wellness TODAY

    22:01
  • Inside the mindset shift behind Americans losing weight

    04:56
  • Pfizer says its 3-dose vaccine will protect kids under 5

    00:28
  • Health officials investigate new monkeypox case in Florida

    01:57
  • Formula crisis: ‘Operation Fly Formula' bound for Indianapolis

    02:29
  • Monkeypox concerns grow as US reports second possible case

    01:58
  • First emergency flights of baby formula expected Sunday

    02:07
  • Hearing-impaired grad pays it forward as an audiology doctor

    03:51
  • Officials investigate possible case of monkeypox in New York

    00:39
  • CDC director signs off on Pfizer COVID booster shot for kids 5-11

    02:30
  • Summer medical checklist: How to get ready for fun in the sun

    04:30

Remdesivir company CEO: It’s ‘not a cure, but a very significant treatment’

08:49

In the wake of a government-sponsored clinical trial that showed promising results for the experimental drug remdesivir to treat coronavirus, Daniel O’Day, chairman and CEO of Gilead Sciences, talks to TODAY in an NBC News exclusive. He says it’s “not a cure, but a very significant treatment” that can “reduce the time it takes patients to get better,” reducing the strain on health care systems. He promises Gilead will work to make the drug “accessible and affordable,” and says they are looking at ways to use the drug for other patients besides the most severely ill.